Literature DB >> 23568042

Pathological characteristics and clinical perspectives of papillary thyroid cancer: study of 714 patients.

Davor Džepina1, Krešo Zurak, Vlado Petric, Hrvoje Čupić.   

Abstract

Papillary thyroid cancer belongs to most commonly diagnosed well-differentiated malignant tumor of the thyroid gland, with only minority of cases being more aggressive, recurring locoregionally and developing distant metastatic foci. The aim of this study was to determine the clinical relationship between parameters of age, gender, size of primary tumor, intraglandular dissemination and regional metastatic spread and evaluate the importance of each parameter; analyze other major aggressive factors (tumor border, thyroid capsule invasion, perivascular, perilymphatic spread) on prevalence and extent of intraglandular dissemination and relation to metastatic spread in neck. This study is a retrospective analysis of clinical and pathological data from 714 patients with papillary thyroid cancer, presented and operated at the Department of ENT/Head and Neck surgery, Sisters of Charity University Hospital, Zagreb, in the period from 1980 to 2008. All patients were operated upon with total thyroidectomy and some type of neck lymphonode dissection (paratracheal or lateral). In results, we found 46.9% tumors were aggressive; 34.7% tumors were multicentric, with foci in the contralateral lobe nearly twice as often as in the ipsilateral lobe; 27.8% were regionally metastatic, with equal distribution between paratracheal and lateral regions. In conclusion, we revealed contralateral lobe multicentricity and male gender as independent risk factors for regional metastatic dissemination. Nodular goiter has been identified as a protective parameter.

Entities:  

Mesh:

Year:  2013        PMID: 23568042     DOI: 10.1007/s00405-013-2472-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  71 in total

Review 1.  Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review.

Authors:  M Urano; M Abe; M Kuroda; Y Mizoguchi; Y Horibe; M Kasahara; K Tanaka; K Sudo; Y Hirasawa
Journal:  Pathol Int       Date:  2001-09       Impact factor: 2.534

Review 2.  A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.

Authors:  J D Brierley; T Panzarella; R W Tsang; M K Gospodarowicz; B O'Sullivan
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

3.  Papillary carcinoma of the thyroid. I. Developing pattern of metastasis.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

4.  Localization of cervical node metastasis of papillary thyroid carcinoma.

Authors:  E Mirallié; J Visset; C Sagan; A Hamy; M F Le Bodic; J Paineau
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

5.  The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Authors:  R W Tsang; J D Brierley; W J Simpson; T Panzarella; M K Gospodarowicz; S B Sutcliffe
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

6.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

7.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

8.  High recurrent rate of multicentric papillary thyroid carcinoma.

Authors:  Jen-Der Lin; Tzu-Chieh Chao; Chuen Hsueh; Sheng-Fong Kuo
Journal:  Ann Surg Oncol       Date:  2009-06-16       Impact factor: 5.344

Review 9.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

10.  Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience.

Authors:  E Baudin; J P Travagli; J Ropers; F Mancusi; G Bruno-Bossio; B Caillou; A F Cailleux; J D Lumbroso; C Parmentier; M Schlumberger
Journal:  Cancer       Date:  1998-08-01       Impact factor: 6.860

View more
  2 in total

1.  Is ultrasonographic evaluation sensitive enough to detect multicentric papillary thyroid carcinoma?

Authors:  Congqing Lu; Yan Wang; Ming Yu
Journal:  Gland Surg       Date:  2020-06

2.  Peritoneal and mediastinal highly differentiated follicular carcinoma of ovarian origin.

Authors:  Kathleen Carey; Manoj Jain; Murli Krishna; Joseph Accurso
Journal:  Indian J Nucl Med       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.